Table 3.
Single-dose sitagliptin pharmacokinetics in the absence and presence of atorvastatin (n=29)
| Pharmacokinetic parameter |
Sitagliptin Geometric Mean (90% CI) |
Sitagliptin + Atorvastatin Geometric Mean (90% CI) |
GMR (90% CI) |
P value |
|---|---|---|---|---|
| Cmax (ng/ml) | 399 (352, 451) | 371 (326, 424) | 0.93 (0.86, 1.01) | 0.16 |
| AUC0-∞ (ng*h/ml) | 3218 (2865, 3614) | 3082 (2696, 3522) | 0.96 (0.91, 1.01) | 0.15 |
| CLRa (ml/min) | 254 (215, 300) | 259 (225, 298) | 1.02 (0.93, 1.12) | 0.69 |
| fea | 0.52 (0.47, 0.58) | 0.51 (0.47, 0.56) | 0.98 (0.90, 1.06) | 0.68 |
| t1/2 (h)b | 7.4 ± 2.5 | 7.0 ± 2.0 | - | 0.39 |
CLR and fe could not be calculated for three subjects due to missing urine samples or incomplete urine collection
arithmetic mean ± standard deviation. GMR=geometric mean ratio; CI=confidence interval.